According to the 2024 IQVIA Use of Medicines report, GLP-1 RAs made up 16% of all diabetes prescriptions in 2023 compared with just 5% in 2019, and that trend has increased 152% since 2018, primarily driven by an increase in uptake of GLP-1 RAs
Dietary Habits While semaglutide helps control appetite, pairing it with a balanced, reduced-calorie diet significantly enhances its effectiveness
They may also be more sensitive to GI side effects
Not for human use, consumption, or therapeutic applications
Feel full longer GLP-1s slow down how quickly food leaves your stomachmaking you feel full faster
A reasonable harm reduction approach for people on cardiovascular medications includes informing healthcare providers about BPC-157 use, starting with conservative doses, monitoring blood pressure and other relevant parameters closely, watching for any changes in medication effectiveness, and being prepared to discontinue if unexpected effects emerge
